Olmesartan Medoxomil
Benicar
Angiotensin 2 Receptor Blocker
NADAC/unit
$0.0581
No Shortage
Tier 1: 189.7%
19 Manufacturers
57 ANDAs
Olmesartan Medoxomil lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.
vs. brand Benicar: Generic saves up to 99% per unit
Generic Manufacturers
ACCORD HEALTHCARE INCALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDAUROBINDO PHARMA LTDCADILA PHARMACEUTICALS LTDCHARTWELL RX SCIENCES LLCCOSETTE PHARMACEUTICALS INCGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT VINVENTIA HEALTHCARE LTDJUBILANT GENERICS LTDMACLEODS PHARMACEUTICALS LTDMICRO LABS LTDMSN LABORATORIES PRIVATE LTDPRINSTON PHARMACEUTICAL INCQILU PHARMACEUTICAL CO LTDSCIEGEN PHARMACEUTICALS INCSUNSHINE LAKE PHARMA CO LTDUMEDICA LABORATORIES PRIVATE LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
